Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Oxybutynin hydrochloride (substance) |
Is a |
False |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxybutynin measurement |
Component |
True |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxybutynin adverse reaction |
Causative agent (attribute) |
True |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Allergy to oxybutynin (finding) |
Causative agent (attribute) |
False |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxybutynin hydrochloride m/r product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxybutynin chloride 2.5 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxybutynin chloride 3 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxybutynin hydrochloride 2.5mg/5mL elixir |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxybutynin hydrochloride 5mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxybutynin hydrochloride 10mg m/r tablet (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing oxybutynin (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxybutynin 3.9mg/day transdermal system |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxybutynin hydrochloride 15mg m/r tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxybutynin-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing oxybutynin in topical dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Allergy to oxybutynin (finding) |
Causative agent (attribute) |
True |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxybutynin hydrochloride (substance) |
Is modification of (attribute) |
True |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Oxybutynin hydrochloride 15mg prolonged-release oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
Product containing oxybutynin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxybutynin only product |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only oxybutynin in cutaneous dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxybutynin only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxybutynin 162 microgram/hour prolonged-release transdermal patch |
Has basis of strength substance (attribute) |
True |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Oxybutynin 162 microgram/hour prolonged-release transdermal patch |
Has precise active ingredient |
True |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing oxybutynin in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
Product containing only oxybutynin in transdermal dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Oxybutynin (substance) |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |